Scope of Pulmonary Rehabilitation in Chronic Respiratory Disease Patients- A Randomized Controlled Trial

Chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), interstitial lung diseases (ILD), bronchiectasis and chronic asthma, contribute 7% to the global burden of disease affecting individuals in both developed and developing countries. Chronic respiratory diseases (CRD) are the third leading cause of death worldwide, and account for 10% of all disability-adjusted life years lost due to disability, it also represents a significant financial burden for patients, families and society. 

People with CRD experience repeated need for hospitalisation, reduced quality of life and life expectancy, poor exercise tolerance and physical functioning, and increased incidence of anxiety and depression.

Despite its proven effectiveness and strong scientific endorsement for routine use in obstructive airway diseases, particularly COPD, and significant benefits in interstitial lung disease, pulmonary rehabilitation remains underutilised. Strategies to enhance access to PR are essential. This study aims to evaluate the efficacy of pulmonary rehabilitation in chronic respiratory disease patients which is carried out in different setups.